Attached files
file | filename |
---|---|
EX-10.1 - EXHIBIT 10.1 - REGENERX BIOPHARMACEUTICALS INC | c25656exv10w1.htm |
EX-10.2 - EXHIBIT 10.2 - REGENERX BIOPHARMACEUTICALS INC | c25656exv10w2.htm |
EX-10.3 - EXHIBIT 10.3 - REGENERX BIOPHARMACEUTICALS INC | c25656exv10w3.htm |
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 30, 2011
REGENERX BIOPHARMACEUTICALS,
INC.
(Exact name of registrant as
specified in its charter)
Delaware | 001-15070 | 52-1253406 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
15245 Shady Grove Road, Suite
470 Rockville, MD |
20850 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (301) 208-9191
Not
Applicable |
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(d) | Exhibits |
Exhibit | ||
Number | Description | |
10.1
|
Second Amendment to the Amended and Restated Employment Agreement between the Company and J.J. Finkelstein, dated December 1, 2011. | |
10.2
|
First Amendment to the Amended and Restated Employment Agreement between the Company and David Crockford, dated December 1, 2011. | |
10.3
|
Second Amendment to the Amended and Restated Employment Agreement between the Company and Allan L. Goldstein, dated December 1, 2011. |
REGENERX BIOPHARMACEUTICALS, INC. |
||||
By: | /s/ J.J. Finkelstein | |||
J.J. Finkelstein | ||||
President and Chief Executive Officer | ||||
Exhibit | ||
Number | Description | |
10.1
|
Second Amendment to the Amended and Restated Employment Agreement between the Company and J.J. Finkelstein, dated December 1, 2011. | |
10.2
|
First Amendment to the Amended and Restated Employment Agreement between the Company and David Crockford, dated December 1, 2011. | |
10.3
|
Second Amendment to the Amended and Restated Employment Agreement between the Company and Allan L. Goldstein, dated December 1, 2011. |